Does morbid obesity negatively impact perioperative outcomes following elective reverse shoulder arthroplasty?: a propensity-matched comparative study
- PMID: 39822832
- PMCID: PMC11733576
- DOI: 10.1016/j.jseint.2024.06.015
Does morbid obesity negatively impact perioperative outcomes following elective reverse shoulder arthroplasty?: a propensity-matched comparative study
Abstract
Background: The incidence of primary reverse total shoulder arthroplasty (rTSA) and the prevalence of obesity have increased in the United States. Despite this, the literature assessing the effect of morbid obesity (body mass index≥40 kg/m2) on perioperative surgical outcomes remains inconsistent.
Methods: A retrospective review of consecutive elective primary rTSA cases from January 2016 through September 2023 at a single tertiary referral center was performed. All cases involved a short-stem humeral component and screw-in glenoid baseplate from the same implant manufacturer. Surgical and patient demographic data were collected. Morbidly obese patients were propensity matched at least 1:1 with non-morbidly obese patients based on age, gender, modified 5-item frailty index score, adjusted Charlson comorbidity index score, and 12-month preoperative emergency department (ED) visit. Regression analysis was utilized to assess the relationship between morbid obesity and operative time, length of stay, intraoperative total blood volume loss, surgical postoperative complications, in-hospital medical complications, disposition, and 90-day ED return and readmission.
Results: There were a total of 175 short-stem rTSA cases performed with a median age of 71 years (interquartile range: 66, 76), of which 19 (10.9%) had a body mass index ≥40 kg/m2. These 19 patients were propensity score matched to 41 non-morbidly obese patients (9 at 1:3, 4 at 1:2, and 6 at 1:1). There were no significant differences between the groups with regard to intraoperative total blood volume loss, operative time, need for transfusion, hospital length of stay, discharge disposition, prevalence for 90-day return to ED, or unplanned 90-day readmission.
Conclusion: Morbid obesity should not be considered an absolute contraindication for elective rTSA, particularly in patients who have undergone appropriate preoperative medical clearance.
Keywords: Length of stay; Morbid obesity; Operative time; Postoperative complications; Readmission; Return to emergency department; Reverse total shoulder replacement.
© 2024 The Authors.
Similar articles
-
Does Morbid Obesity (BMI ≥40 kg/m2) Impact Operative Time, Blood Loss, Length of Stay, or Complications Following Anatomic Total Shoulder Arthroplasty?Arch Bone Jt Surg. 2023;11(6):389-397. doi: 10.22038/ABJS.2023.70400.3306. Arch Bone Jt Surg. 2023. PMID: 37404299 Free PMC article.
-
Outcomes and Costs of Reverse Shoulder Arthroplasty in the Morbidly Obese: A Case Control Study.J Bone Joint Surg Am. 2014 Jul 16;96(14):1169-1176. doi: 10.2106/JBJS.M.00735. J Bone Joint Surg Am. 2014. PMID: 25031371
-
Effect of Body Mass Index on Outcomes After Surgery for Perforated Diverticulitis.J Surg Res. 2020 Mar;247:220-226. doi: 10.1016/j.jss.2019.10.020. Epub 2019 Nov 7. J Surg Res. 2020. PMID: 31708198
-
Clinical outcomes of reverse total shoulder arthroplasty for elective indications versus acute 3- and 4-part proximal humeral fractures: a systematic review and meta-analysis.J Shoulder Elbow Surg. 2022 Jan;31(1):e14-e21. doi: 10.1016/j.jse.2021.07.014. Epub 2021 Aug 25. J Shoulder Elbow Surg. 2022. PMID: 34454040
-
Risk of poor outcomes in patients who are obese following total shoulder arthroplasty and reverse total shoulder arthroplasty: a systematic review and meta-analysis.J Shoulder Elbow Surg. 2019 Nov;28(11):e359-e376. doi: 10.1016/j.jse.2019.06.017. J Shoulder Elbow Surg. 2019. PMID: 31630753
References
LinkOut - more resources
Full Text Sources